Elizabeth Jungman joined Hogan Lovells as a partner in its pharmaceuticals and biotechnology practice in Washington, DC, the firm announced Monday.
Jungman brings deep FDA experience through her leadership across multiple branches of government and advises senior agency officials on drug policy development, implementation, and strategic goals. She has built a career focused on the development, interpretation, and application of pharmaceutical laws and regulations, the firm said.
She joins from the US Food and Drug Administration.
This story was produced by Bloomberg Law Automation.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.